Nephros, Inc.NEPHNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$1.29M
↑ 161% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-2.10M
Historical baseline
PeriodValueYoY Change
TTM$1.29M+466.5%
2024$227000.00+116.7%
2023$-1.36M+63.1%
2022$-3.69M-48.0%
2021$-2.49M+40.8%
2020$-4.21M-39.8%
2019$-3.01M+2.4%
2018$-3.08M-48.4%
2017$-2.08M+21.0%
2016$-2.63M-